KR19980069516A - Extract and skin cosmetic containing same - Google Patents
Extract and skin cosmetic containing same Download PDFInfo
- Publication number
- KR19980069516A KR19980069516A KR1019970006624A KR19970006624A KR19980069516A KR 19980069516 A KR19980069516 A KR 19980069516A KR 1019970006624 A KR1019970006624 A KR 1019970006624A KR 19970006624 A KR19970006624 A KR 19970006624A KR 19980069516 A KR19980069516 A KR 19980069516A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- water
- skin
- effect
- skin cosmetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000284 extract Substances 0.000 title claims abstract description 57
- 239000002537 cosmetic Substances 0.000 title claims abstract description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 48
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000000203 mixture Substances 0.000 claims abstract description 17
- 229940058015 1,3-butylene glycol Drugs 0.000 claims abstract description 13
- 235000019437 butane-1,3-diol Nutrition 0.000 claims abstract description 13
- 239000000843 powder Substances 0.000 claims abstract description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 23
- 238000002156 mixing Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 27
- 230000002087 whitening effect Effects 0.000 abstract description 15
- 230000003078 antioxidant effect Effects 0.000 abstract description 13
- 239000000469 ethanolic extract Substances 0.000 abstract description 9
- 230000006872 improvement Effects 0.000 abstract description 6
- 230000037380 skin damage Effects 0.000 abstract description 6
- 230000002265 prevention Effects 0.000 abstract description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 16
- 235000009852 Cucurbita pepo Nutrition 0.000 description 15
- 241000219122 Cucurbita Species 0.000 description 14
- 102000003425 Tyrosinase Human genes 0.000 description 10
- 108060008724 Tyrosinase Proteins 0.000 description 10
- 235000013399 edible fruits Nutrition 0.000 description 10
- 230000005764 inhibitory process Effects 0.000 description 10
- 235000019441 ethanol Nutrition 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 9
- 239000003112 inhibitor Substances 0.000 description 8
- 239000006071 cream Substances 0.000 description 7
- 230000008099 melanin synthesis Effects 0.000 description 7
- 239000000049 pigment Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 6
- 230000003061 melanogenesis Effects 0.000 description 6
- 230000003647 oxidation Effects 0.000 description 6
- 238000007254 oxidation reaction Methods 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 201000001441 melanoma Diseases 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000007760 free radical scavenging Effects 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 241000186361 Actinobacteria <class> Species 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 206010014970 Ephelides Diseases 0.000 description 3
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 3
- 208000003351 Melanosis Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000011888 foil Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 3
- 235000020778 linoleic acid Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 229960004441 tyrosine Drugs 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- 241000219104 Cucurbitaceae Species 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 2
- 244000303847 Lagenaria vulgaris Species 0.000 description 2
- 235000009797 Lagenaria vulgaris Nutrition 0.000 description 2
- 201000005702 Pertussis Diseases 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 235000021028 berry Nutrition 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 229960004337 hydroquinone Drugs 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 2
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 2
- 229960004705 kojic acid Drugs 0.000 description 2
- 229940010454 licorice Drugs 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 2
- -1 polyoxyethylene monooleate Polymers 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000001382 Experimental Melanoma Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000218213 Morus <angiosperm> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 229920001007 Nylon 4 Polymers 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000121220 Tricholoma matsutake Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- SOIFLUNRINLCBN-UHFFFAOYSA-N ammonium thiocyanate Chemical compound [NH4+].[S-]C#N SOIFLUNRINLCBN-UHFFFAOYSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 235000011869 dried fruits Nutrition 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229960002089 ferrous chloride Drugs 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000009454 functional inhibition Effects 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- ZUVVLBGWTRIOFH-UHFFFAOYSA-N methyl 4-methyl-2-[(4-methylphenyl)sulfonylamino]pentanoate Chemical compound COC(=O)C(CC(C)C)NS(=O)(=O)C1=CC=C(C)C=C1 ZUVVLBGWTRIOFH-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
본 발명은 박추출물 및 이를 함유하는 피부화장료에 관한 것으로, 피부손상방지 및 개선효과, 미백효과, 항산화효과 등이 탁월하고 안전성면에서도 우수한 박분말의 물중탕처리 물추출물, 60~95% 에탄올추출물, 1,3-부틸렌글리콜 및 물의 혼합액으로 추출한 박추출물로서 피부화장료의 성분으로서 적용가능한 것이다.The present invention relates to a thin extract and a skin cosmetic containing the same, the water extract of water powder treatment, 60-95% ethanol extract of thin powder excellent in safety and prevention of skin damage and improvement effect, whitening effect, antioxidant effect, etc. As a thin extract extracted with a mixture of 1,3-butylene glycol and water, it is applicable as a component of skin cosmetics.
Description
본 발명은 박추출물 이를 함유하는 피부화장료에 관한 것으로 특히 피부손상방지 및 개선효과, 미백효과, 항산화효과 등이 탁월하고 안전성면에서도 우수하여 피부화장료의 성분으로서 적용가능한 박의 물중탕처리 물추출물, 60~95% 에탄올추출물, 1,3-부틸렌글리콜(1,3-butylene glycol) 및 물의 혼합액으로 추출한 박추출물과 이를 함유하는 피부화장료에 관한 것이다.The present invention relates to a skin cosmetic containing the extract of the same, in particular, it is excellent in the skin damage prevention and improvement effect, whitening effect, antioxidant effect, and also excellent in terms of safety, water extract treatment water extract of gourd, which is applicable as a component of skin cosmetic, It relates to a skin extract extracted with a mixture of 60 ~ 95% ethanol extract, 1,3-butylene glycol (1,3-butylene glycol) and water and skin cosmetics containing the same.
일반 피부외용제에는 화장료, 의약품, 의약부외품 등이 있고 특히 피부손상의 방지 및 개선을 목적으로 한 피부외용제에 대해서는 종래부터 천연물로부터 추출한 원료를 시작으로 여러가지의 원재료를 배합하여 사용하고 있다. 예를 들면, 인삼추출물과 효모추출물, 송이버섯 추출물 등의 추출물, 콜라겐 등의 천연고분자, 아미노산, 비타민 등의 피부부활제 혹은 글리세린, 1,3-부틸렌글리콜 등의 보습제 등이 피부손상의 방지 및 개선을 목적으로 피부화장료에 이용되어 오고 있었다.General external skin preparations include cosmetics, medicines, and quasi-drugs. Especially, external skin preparations for the purpose of preventing and improving skin damage have been conventionally used in combination with various raw materials including raw materials extracted from natural products. For example, ginseng extract, yeast extract, extracts such as pine mushroom extract, natural polymers such as collagen, skin rejuvenating agents such as amino acids and vitamins, or moisturizing agents such as glycerin and 1,3-butylene glycol are used to prevent skin damage. And it has been used in skin cosmetics for the purpose of improvement.
박은 아프리카 또는 열대 아시아 원산(原産)이며 재배작물로 들여와 우리나라 전국 각처의 농가에서 흔히 심고 있으며 지붕위로 타고 올라가는 덩굴풀로서 이 덩굴의 열매를 박이라 한다. 박의 학명은 Lagenaria leucantha RUSBY이고, 속명은 여러 가지가 있으며 호과(瓠瓜), 첨호(甛瓠), 포로(匏蘆), 포(匏), 호로(壺盧), 호서(瓠犀), 호자(瓠子), 포과(匏瓜), 박아지, 호로박, 참조롱박, 박꼬지, 박속, 동과자(冬瓜子), 동과씨로도 불리고 있다. 특징은 오이과의 1년생 덩굴풀로서 귀화식물(歸化植物)이다(김태정, 한국의 자원식물 IV, 서울대학교 출판부, 1996).Park is native to Africa or tropical Asia, and is commonly used in farms all over Korea. It is a vine grass that climbs on the roof. The fruit of this vine is called Park. Park's scientific name is Lagenaria leucantha RUSBY, and there are various genus names. Ho, Ho, Ho, Pho, Po, Horo, Hoseo, Hoja (포 子), poins (匏 瓜), bakahji, horobak, reference longbak, bakkoji, baksok, dongja (冬瓜 子), dongwa seeds are also called. It is characterized as a yearly vine of cucumber family, naturalized plant (Kim Tae-jung, Korea Resource Plant IV, Seoul National University Press, 1996).
박은 일반적으로 길이 5m 내외로 뻗으며 전체에 짧은 털이 있고 덩굴손으로 감으면서 뻗는다. 7~9월에 꽃이 피는데 꽃은 흰색이며 저녁 때나 해질 무렵에 피고 해가 뜨면 시드는 특징이 있다. 지름은 5~10cm로서 다섯개로 갈라진다. 10월에 장과(漿果 : 살과 물이 많고 속에 씨가 많은 열매)가 여무는데 장과는 지름 30cm 이상이며 익으면 겉껍질이 딱딱해진다. 박의 속은 먹기도 하고 가늘게 쪼개서 약으로 쓰기도 하였다. 또한, 호로를 잘게 쪼개서 호로 기름을 내기도 하며 잘 익은 껍질은 용기로 사용하기도 해쏙, 우리나라와 만주의 인가에서는 집 주위에서 재배했다고 한다(김태정, 약이 되는 한국의 산야초, 국일미디어, 1996).The gourd generally extends about 5m long, with short hairs all over, and wrapped with tendrils. Flowers bloom in July-September. Flowers are white and bloom in the evening or at dusk. It is 5 ~ 10cm in diameter and divided into 5 pieces. In October, berry (漿果: flesh and water, fruit with a lot of seeds in the middle) is a berry is more than 30cm in diameter, and when it is ripe, the outer shell becomes hard. The inside of the gourd was eaten or thinly divided into medicine. In addition, the horo may be chopped into small pieces to make oil, and the ripe skin may be used as a container.In Korea and Manchuria, it is said to be grown around the house (Kim Tae-jung, Sanyacho of Korea, Kookil Media, 1996).
박은 작은 것과 큰 것 두 종(種)이 있고, 열매가 긴 것과 둥근 것이 있다. 우리나라의 경우 둥근 것은 새로 나온 곱고 연한 잎과 겉껍질 부드러운 것을 나물로 먹거나 잘게 절단하여 박꼬지를 만들고, 또한 솥에 쪄서 즙을 내어 먹기도 했다고 한다. 또한, 박아지를 반으로 쪼개서 기물을 담기도 했다고 하는데 이것을 속칭 박 또는 박아지라 불렀다. 박아지는 곡식의 저장용기로도 사용되었고, 중국인들은 겉껍질을 식용으로 하며, 콩이나 면의 제조용기로 두루 쓰였다고 기록되어 있다.There are two kinds of gourds: small and large, long fruit and round. In Korea, it is said that the round ones are made with fresh or soft leaves and soft skins with fresh herbs or finely cut to make bakkoji and steamed in a pot to eat juice. In addition, he divided pieces into pieces and contained objects. These were called “bakes” or “bakes”. It is also used as a storage container for grains, and it is reported that the Chinese used the outer shell for food and were used for making beans or noodles.
또한, 종자를 호자(瓠子) 또는 과자아(瓜子兒), 서과(西瓜), 남과(南瓜)라 부르기도 했다. 종자는 우리나라는 물론 중국인들까지 간식물(間植物)로 널리 이용했다. 표주박을 반으로 절단하여 물을 마시거나 담기 위한 기구로 사용하였는데 이를 수표자(水瓢子)라 하였다고 소개되어 있다. 박은 식용, 관상용, 공업용으로 사용되고 열매의 내피(內皮)는 식용으로 사용되며 관상초 및 공예품 등에 쓰이는 것으로 알려지고 있다.The seeds were also called hoja or confectionery, western and southern families. Seeds were widely used as snacks by Chinese as well as Koreans. The gourd was cut in half and used as a device for drinking or containing water. It is introduced as a checker (水瓢 子). It is known that gourd is used for edible, ornamental and industrial purposes, and the endothelial of fruit is used for edible and is used for ornamental vinegar and crafts.
박의 효능은 예로부터 여러 가지가 알려져 있는데 특히 이뇨, 백일해, 중독, 주근깨 치료효과가 있다. 그 이외에 민간요법으로서 ① 식용, 공업용, 관상용, 약용에 쓰인다. 열매의 껍질을 말린 것에 감초를 섞어 달여 마시면 백일해 또는 기침멎이에 좋다, 또한, 과실의 껍질에 대나무 잎을 넣어 달여 마셔도 좋다. ② 종자 또는 껍질 말린 것을 달여 마시거나 또는 과살의 살을 요리해서 먹으면 이뇨(利尿)에 효과가 있으며 수종, 각기, 치질, 월경불순 등에도 좋은 효과를 볼 수 있다. ③ 어류, 게류, 버섯류의 중독에는 과실의 껍질을 달여 마시기도 하며 과실의 짠즙을 마셔도 좋다. ④ 주근깨에는 과실을 잘게 썰어 씨앗과 함께 물과 술로 달여 이것을 걸러 낸다. 걸러 낸 즙을 반으로 졸요 장기간에 걸쳐 주근깨가 핀 얼굴 등에 바르면 효과가 있다. 또한, 종자를 잘게 썰어 여기에 복숭아꽃을 같은 양으로 섞어 꿀로 반죽한 것을 발라도 좋다. ⑤ 치질의 경우에는 종자를 단일 즙으로 환부를 씻으면 좋다. 아울러 어린이 설사에는 과실을 으깨어 그 즙을 마시게 하면 좋다는 내용 등이 있다.The efficacy of gourd has been known for many years, especially diuretic, whooping cough, poisoning, and freckles. In addition to folk remedies ① edible, industrial, ornamental, medicinal is used. Dried fruit bark mixed with licorice is good for pertussis or coughing. You can also add bamboo leaves to the fruit bark for sweetening. ② Dried or dried flesh of the seeds or dried flesh to eat is effective in diuresis (利尿) and can be good for species, each, hemorrhoids, irregular menstruation. ③ Fish, crabs, mushrooms addiction to the skin of the fruit may be drunk or drink the salty juice of the fruit. ④ chop the fruit into freckles, strain with water and alcohol with seeds to filter this. Scoop out the juice in half and apply it to your face or freckles over long periods of time. You can also finely chop the seeds, mix the same amount of peach blossom and knead it with honey. ⑤ in case of hemorrhoids, wash the affected part with a single juice. In addition, children's diarrhea may crush fruit and drink the juice.
그러나, 이러한 민간전래의 효능이 있음에도 불구하고 실제적으로 국내에서 박에 대한 연구는 전무한 실정이다.However, despite the efficacy of folklore, there is virtually no research on Park in Korea.
본 발명의 목적은 각종 피부손상의 방지 및 개선효과가 탁월하고 안전성면에서도 우수한 박추출물 이를 함유하는 피부화장료를 제공하는 것이다. 즉, 피부화장료에 적용 가능하고 화장료에 함유시 우수한 미백효과, 항산화효과 등을 나타내는 박추출물을 제공하는 것이다.It is an object of the present invention to provide a skin cosmetic containing the same extract that is excellent in safety and excellent in preventing and improving various skin damages. That is, to provide a skin extract that is applicable to skin cosmetics and exhibits excellent whitening effect, antioxidant effect, etc. when contained in cosmetics.
상기한 목적을 달성하기 위한 본 발명의 박추출물은 박분말의 물중탕처리 물추출물, 60~95% 에탄올추출물 또는 1,3-부틸렌글리콜 및 물의 혼합액으로 추출한 추출물이다. 또한, 상기한 박추출물은 피부화장료의 성분으로서 적용가능하며 이때 박추출물의 함유량은 0.05~20 중량%인 것이 바람직하다.The extract of the present invention for achieving the above object is an extract of a powdered water-treated water extract, 60 ~ 95% ethanol extract or a mixture of 1,3-butylene glycol and water. In addition, the thin extract is applicable as a component of the skin cosmetic, wherein the content of the thin extract is preferably 0.05 to 20% by weight.
본 발명에서는 국내에서 재배한 박의 물중탕처리 물추출물과, 60~95% 에탄올추출물, 1,3-부틸렌글리콜 및 물의 혼합액으로 추출한 박추출물에서 화장료에 이용할 수 있는 효과가 입증되고 화장료에 함유시 우수한 항산화효과, 미백효과 등이 발견되어 본 발명을 완성하게 된 것이다.In the present invention, the effect that can be used in cosmetics in the water extract of the water-treated water extract of Park, cultivated in Korea, 60-95% ethanol extract, 1,3-butylene glycol and water mixture is proved and contained in cosmetics Excellent antioxidant effect, whitening effect, etc. have been found to complete the present invention.
우선, 박추출물의 피부화장료에 대한 이용가능성을 확인하기 위하여 미백효과, 항산화효과 등을 조사했다. 박은 국내의 충북 음성에서 노지재배한 것을 사용하였으며 시료로 사용하기 위해 9월경에 완전히 익은 박을 채취하여 쪼갠 후 박열매 중 씨와 그외 나머지 부분을 분리하고 씨를 제외한 나머지 부분을 시료로 하였다(이하 이 부분을 박이라 함). 박은 실온에서 중량의 변화가 없을 때까지 건조시킨 후, 질소탱크에 넣어 얼리고 막자사발로 갈아 분말로 하였다. 박분말의 물중탕처리 물추출물, 60~95% 에탄올추출물, 1,3-부틸렌글리콜 및 물의 혼합액으로 추출한 박추출물을 시료로 사용하였다.First, the whitening effect and antioxidant effect were investigated to confirm the applicability of skin extracts to skin cosmetics. Park used field cultivation in Numseong-si, Chungbuk, Korea. To use it as a sample, it was taken and sliced a fully ripe gourd around September, and the seeds and other parts of the park fruit were separated and the remaining parts except seeds were used as samples. Part is called gourd). The foil was dried at room temperature until there was no change in weight, then placed in a nitrogen tank and frozen, and ground in a mortar to obtain a powder. The water extract of the powdered water, the water extract extracted with a mixture of 60-95% ethanol extract, 1,3-butylene glycol and water was used as a sample.
피부화장료로 응용하기 위한 효과 테스트로 프리라디칼 소거작용을 조사하였다. 그 결과 3 중량% 시료농도에서 가장 높은 프리라디칼 소거작용을 나타내었다. 1,1-디페닐-2-피크릴히드라질(DPPH) 농도의 50%를 감소시키는데 필요한 시료의 농도(SC50)는 0.4중량%이었고, 효과면에서 다른 어떤 물질보다도 우수하였다.The effect of free radical scavenging was examined as an effect test for application to skin cosmetic. As a result, it showed the highest free radical scavenging effect at 3% by weight sample concentration. The sample concentration (SC 50 ) required to reduce 50% of the 1,1-diphenyl-2-picrylhydrazyl (DPPH) concentration was 0.4% by weight and was superior to any other material in effect.
리놀산 자동산화를 이용한 항산화효과 테스트에서 박 에탄올추출물은 항산화효과가 대조군에 비해 뛰어난 비타민 E(42.3%)에 비해 우수한 항산화효과(44%)를 나타냈다.In the antioxidant effect test using linoleic acid automatic oxidation, Park ethanol extract showed superior antioxidant effect (44%) compared to vitamin E (42.3%), which was superior to the control group.
티로시나제 활성 저해능, 방선균(Strepthmyces bikiniensis)의 멜라닌 생성 저해능, B16-F1 멜라노마 세포의 멜라닌 생성 저해능 등의 실험으로 박추출물에 대한 미백효과를 조사하였다. 그 결과, 티로시나제 활성을 50% 저해하는 농도(IC50)는 0.2%이하였고, 0.005%의 농도에서 멜라닌 생성 영역을 20mm 저해하였다. 또한 B16-F1 멜라노마 세포의 멜라닌 생성을 저해하는 최소 농도는 0.1%로 나타나 피부외용제 특히 피부화장료로서 우수한 효과를 나타냈다.The whitening effect on the extracts was examined by experiments of tyrosinase activity inhibitory activity, melanin production inhibition of Strepthmyces bikiniensis, and melanin production inhibition of B16-F1 melanoma cells. As a result, the concentration (IC 50 ) that inhibits tyrosinase activity by 50% was 0.2% or less, and the melanin-producing region was inhibited by 20 mm at a concentration of 0.005%. In addition, the minimum concentration of inhibiting melanin production of B16-F1 melanoma cells was 0.1%, showing an excellent effect as an external preparation for skin, especially skin cosmetics.
본 발명의 박추출물을 함유한 피부화장료로서 적용예는 현재까지 보고된 바 없다. 이 박추출물의 피부화장료에의 배합량은 한정된 것은 아니지만 0.05~20중량%가 적당한 것으로 나타났으며 너무 적은 함량에서는 효과를 기대하기 어렵고, 너무 많은 함량에서는 그 이상 배합해도 효과가 크게 증가하지 않았다.Examples of application as skin cosmetics containing the extract of the present invention have not been reported to date. The amount of this extract to the skin cosmetic was not limited, but 0.05 to 20% by weight was found to be suitable, and the effect was not expected at too small content, and the effect was not greatly increased even if blended more than too much.
또한, 본 발명의 추출물은 물에 쉽게 혼화되고 유지와 유기성 용매에는 혼화가 어렵지만 현탁상태에서도 피부화장료에 배합은 가능하고 효과에 대하여 어떠한 영향도 주지 않는다. 본 발명의 피부외용제는 피부화장료로서 이용되는 것이 적당하며 일반 피부화장료에 배합되는 보통의 성분 예를 들면 유분, 물, 계면활성제, 보습제, 저급알콜, 증점제, 킬레이트제, 색소, 방부제, 향료 등을 필요한 만큼 적용배합하는 것이 가능하다. 본 발명에서 피부화장료는 피부에 사용하는 것으로서 예를 들면, 화장수, 유액, 크림, 팩 등의 화장료와 특히 미백화장료에의 응용이 대표적이다.In addition, the extract of the present invention is easily mixed with water and difficult to blend with fats and oils and organic solvents, but can be blended into the skin cosmetic even in a suspended state and has no effect on the effect. The external skin preparation of the present invention is suitable to be used as a skin cosmetic, and common ingredients such as oil, water, surfactants, moisturizers, lower alcohols, thickeners, chelating agents, pigments, preservatives, fragrances, etc. It is possible to combine them as necessary. In the present invention, the skin cosmetic is used for the skin, for example, a cosmetic, such as a lotion, milky lotion, cream, pack, and the application in particular to the whitening cosmetics.
이하, 실시예에 의해 본 발명을 보다 상세히 설명한다.Hereinafter, the present invention will be described in more detail with reference to Examples.
이들 실시예는 본 발명의 예시적인 기재일 뿐이며 본 발명의 범위가 이들 실시예에 국한되는 것은 아니다.These examples are merely illustrative of the present invention and the scope of the present invention is not limited to these examples.
[실시예 1]Example 1
박(Lagenaria leucantha RUSBY)은 국내의 충북 음성에서 노지재배한 참조롱박, 표주박 등을 사용하였으며 시료로 사용하기 위해 9월경에 완전히 익은 박은 채취하여 쪼갠 후 박열매중 씨와 그외 나머지 부분을 분리하고 씨를 제외한 나머지 부분을 시료로 하였다. 박은 실온에서 중량의 변화가 없을 때까지 건조시킨 후, 액체질소탱크에 넣어 얼려 잘 부스러지게 한 후 막자사발로 갈아 분말로 하였다.Park (Lagenaria leucantha RUSBY) used the reference long bak, gourd, etc., which was cultivated in the voice of Chungbuk, Korea. The remaining part was used as a sample. The foil was dried at room temperature until there was no change in weight, and then placed in a liquid nitrogen tank to freeze and crumbled.
용매추출하기 위해서 3종류의 용매를 사용하였다. 첫번째가 증류수이고, 두번째가 에탄올, 세번째가 1,3-부틸렌글리콜과 물의 혼합물이다.Three solvents were used for solvent extraction. The first is distilled water, the second is ethanol, and the third is a mixture of 1,3-butylene glycol and water.
물에 의한 추출은 물에 10~30중량% 농도로 박분말을 넣고 40~80℃에서 48~100시간 물중탕한 후 400메쉬크기의 쇠그물망으로 여과하여 박과 여과액을 분리하였다. 계속해서 분리된 여과액을 0.45㎛ 여과지로 제균여과하여 시료로 사용하였다. 박분말은 10중량% 미만으로 사용하면 추출물의 효능, 효과가 떨어지고, 30중량%를 초과하여 사용하면 액상에 박분말이 모두 잠기지 않아 추출시 문제점이 있다. 또한, 물중탕처리를 100시간 이상해도 더 이상의 효과는 나타나지 않는다.Extraction by water was put into 10 ~ 30% by weight of the powder powder in water, and water-bathed at 40 ~ 80 ℃ 48 ~ 100 hours and filtered through a mesh mesh of 400 mesh size to separate the foil and filtrate. Subsequently, the separated filtrate was sterilized by 0.45 μm filter paper and used as a sample. When the powder powder is used in less than 10% by weight, the efficacy of the extract, the effect is reduced, and when used in excess of 30% by weight, there is a problem in extracting the powder powder is not submerged in the liquid. In addition, even if the water bath treatment is performed for 100 hours or more, no further effect is exhibited.
에탄올에 의한 추출은 물에 대한 60%, 80%, 95% 에탄올용액에 박은 10~30중량% 농도로 첨가하여 15~60일간 25~60℃에 침지하되 온도를 1일 간격으로 순환시키는 것이 한가지 온도로 고정시키는 것 보다 추출물의 효과가 높게 나타났다. 이 과정이 끝나면 추출액을 400메쉬크기의 그물망으로 여과하여 박과 여과액을 분리하고 이 분리된 여과액을 0.45㎛ 여과지로 여과하여 시료로 사용하였다.Extraction by ethanol is added in 10 ~ 30% by weight in 60%, 80%, 95% ethanol solution in water and soaked in 25 ~ 60 ℃ for 15 ~ 60 days, but the temperature is circulated every day. The effect of the extract was higher than fixation at temperature. After this process, the extract was filtered through a mesh of 400 mesh size to separate the gourd and the filtrate, and the separated filtrate was filtered with 0.45 μm filter paper and used as a sample.
1,3-부틸렌글리콜과 물의 환합액에 의한 추출에서는 1,3-부틸렌글리콜과 물의 비율을 8 : 2 내지 4 : 6의 중량비로 혼합하고 이 혼합액에 10~30중량% 농도로 박을 첨가하고 40~80℃에서 8~48시간 물중탕하여 추출한 후 400메쉬크기의 쇠그물망으로 여과하여 박과 여과액을 분리한 다음 여과액을 0.45㎛ 여과지로 여과하여 시료로 사용하였다.In the extraction by using a mixture of 1,3-butylene glycol and water, the ratio of 1,3-butylene glycol and water is mixed in a weight ratio of 8: 2 to 4: 6, and the mixture is mixed with 10 to 30% by weight. After extraction, the mixture was extracted with a water bath at 40-80 ° C. for 8-48 hours, filtered through a mesh mesh of 400 mesh size to separate the gourd and the filtrate, and the filtrate was filtered with 0.45 μm filter paper to be used as a sample.
[실시예 2]Example 2
본 실시예는 프리라디칼 소거작용효과를 관찰한 것이다.In this example, the effect of free radical scavenging was observed.
0.2mM 1,1-디페닐-2-피크릴히드라질(1,1-diphenyl-2-picrylhydrazyl, DPPH)메탄올용액 0.5ml에 여러농도의 물중탕처리 물추출물, 에탄올 추출물, 1,3-부틸렌글리콜과 물의 혼합액으로 추출한 추출물 각각의 10% 에탄올용액 1ml을 첨가하고 섞은 다음 37℃에서 10분간 방치 후 517mm에서 흡광도의 감소를 측정했다. 그 결과, 프리라디칼 소거능력과 프리라디칼을 50% 감소시키는 농도(SC50)는 아래식과 같이 구하였다. 그 결과 시료 3중량% 정도에서 최대능을 나타냈으며 SC50은 0.4중량%로 나타났다(표 1). 이것은 다른 어느 물질보다도 우수한 효과가 있는 것이다.0.2mM 1,1-diphenyl-2-picrylhydrazyl (1,1-diphenyl-2-picrylhydrazyl, DPPH) Methanol solution in 0.5 ml of various concentrations of water extract, ethanol extract, 1,3-butyl 1 ml of 10% ethanol solution of each extract extracted with a mixture of len glycol and water was added and mixed, and then left for 10 minutes at 37 ° C. and then the absorbance was decreased at 517 mm. As a result, the free radical scavenging ability and the concentration (SC 50 ) which reduces the free radical 50% were calculated as follows. As a result, the maximum performance was shown in about 3% by weight of the sample and SC 50 was 0.4% by weight (Table 1). This has a superior effect than any other material.
* 프리라디칼 억제율(%)=[1-(E-B)/C]×100* Free radical inhibition rate (%) = [1- (E-B) / C] × 100
(B : 대조군, C : 기준군, E : 시료군)(B: control group, C: reference group, E: sample group)
* 소거능력(SC50) : 활성의 크기는 1,1-디페닐-2-피크릴히드라질(66.7㎛)농도가 50% 감소되는데 필요한 시료의 농도로 표기했다.* Scavenging ability (SC 50 ): The size of the activity is expressed as the concentration of the sample required to reduce the 1,1-diphenyl-2-picrylhydrazyl (66.7㎛) concentration by 50%.
[표 1]TABLE 1
[실시예 3]Example 3
본 실시예는 자동산화가 잘 되는 물질인 리놀산을 이용하여 자동산화를 억제하는 정도를 상호 비교한 것이다. 8ml 캡튜브에 10mM 리놀산용액 3ml와 4mg/ml로 조정한 시료 0.075ml를 첨가한 후 4℃에 방치한다. 상기의 혼합액 0.1ml를 24시간 후에 75% 에탄올수용액 4.7ml에 첨가하여 교한한 후, 30% 티오시안산암모늄 용액 0.1ml와 염화제1철 시약 0.1ml를 첨가하고 3분간 방치한 후 발색시켜 500nm에서 흡수파장을 측정, 시료를 넣지 않은 대조군과 바교하여 항산화효과를 백분율로 측정했다. 리놀산 자동산화를 이용한 항산화효과 시험에서 실시예 1에 의해 추출한 박추출물은 항산화효과가 대조군에 비해 뛰어나 비타민 E(42.3%)에 비해 우수한 항산화효과(44%)를 가진 것으로 나타났다(표 2).This embodiment compares the degree to which the automatic oxidation is suppressed by using linoleic acid, which is a good automatic oxidation material. 3 ml of 10 mM linoleic acid solution and 0.075 ml of the sample adjusted to 4 mg / ml are added to an 8 ml cap tube, and the mixture is left at 4 ° C. After 0.1 ml of the mixed solution was added to 4.7 ml of 75% aqueous ethanol solution after 24 hours, 0.1 ml of 30% ammonium thiocyanate solution and 0.1 ml of ferrous chloride reagent were added and left for 3 minutes, followed by color development. Absorption wavelength was measured at, and the antioxidant effect was measured as a percentage in comparison with the control group. In the antioxidant effect test using linoleic acid automatic oxidation, the extract extracted by Example 1 was found to have an excellent antioxidant effect (44%) compared to vitamin E (42.3%) because the antioxidant effect is superior to the control (Table 2).
[표 2]TABLE 2
[실시예 4]Example 4
본 실시예는 실시예 1에 의해 추출한 박추출물의 미백효과를 알아보기 위해 티로시나제(tyrosinase)라는 효소가 기능억제되는 정도를 보고 미백효과를 판단한 것이다.This embodiment is to determine the whitening effect by looking at the degree of functional inhibition of the enzyme tyrosinase (tyrosinase) to determine the whitening effect of the extract extracted by Example 1.
티로시나제는 생체내에서 티로신(tyrosine)이라는 물질의 산화과정을 촉진하여 멜라닌이 생성되게 도와주는 효소이다. 본 실시예에서는 이 효소의 기능을 억제하여 티로신이 산화되어 멜라닌이라는 흑색의 고분자를 형성하는 것을 억제하는 정도를 측정하는 방법(Pomerantz S. H., J. Biochem., 24, 161-168 (1996))을 응용해 미백효과로 판정하였다.Tyrosinase is an enzyme that accelerates the oxidation of tyrosine in vivo and helps melanin production. In this example, a method of inhibiting the function of this enzyme to inhibit the oxidation of tyrosine to form a black polymer called melanin (Pomerantz SH, J. Biochem., 24, 161-168 (1996)) Application was judged as a whitening effect.
상백피추출물(원액, 10, 1, 0.1, 0.01의 증류수에 대한 v/v%), 박추출물(원액, 0.2, 0.05, 0.005, 0.0005의 증류수에 대한 v/v%), 유용성 감초추출물, 코직산, 알부틴, 하이드로퀴논(1, 0.1, 0.01, 0.0001, 0.0001의 증류수에 대한 v/v%)을 시료로 사용하여 티로시나제 활성 억제효과를 조사하였다.Morus extract (stock solution, v / v% of distilled water of 10, 1, 0.1, 0.01), gourd extract (stock solution, v / v% of distilled water of 0.2, 0.05, 0.005, 0.0005), oil-soluble licorice extract, kojic acid, Arbutin and hydroquinone (v / v% of distilled water of 1, 0.1, 0.01, 0.0001, 0.0001) were used as samples to investigate the inhibitory effect of tyrosinase activity.
티로시나제에 대한 저해활성은 시료 15㎕를 마이크로플레이트(96웰)에 넣고, 0.1M 인산완충액(pH6.86) 150㎕, 1.5mM L-티로신용액 25㎕를 넣은 후, 2,380단위/㎖ 머쉬룸 티로시나제(Sigma, USA)(0.05M 인산완충액, pH6.86) 7㎖를 첨가하여 30℃에서 10분간 반응시킨 후 마이크로플레이트를 사용하여 490nm에서 측정하였다. 티로시나제에 대한 저해율(%)은 다음 식에 의하여 계산하였으며, IC50값은 효소활성 저해율 50%에 달하는 저해물질의 농도이다(표 3).For inhibitory activity against tyrosinase, 15 μl of the sample was placed in a microplate (96 well), 150 μl of 0.1 M phosphate buffer (pH6.86) and 25 μl of 1.5 mM L-tyrosine solution were added, followed by 2,380 units / ml of mushroom tyrosinase ( Sigma, USA) (0.05M phosphate buffer, pH6.86) was added to the reaction for 10 minutes at 30 ℃ was measured at 490nm using a microplate. Inhibition rate for tyrosinase (%) was calculated by the following equation, IC 50 value is the concentration of the inhibitor reaches 50% enzyme inhibition rate (Table 3).
저해율(%)={[(D-C)-(B-A)]/(D-C)}×100% Inhibition = {[(D-C)-(B-A)] / (D-C)} × 100
A : 저해제를 넣은 것의 반응 전 흡광도A: absorbance before reaction of the inhibitor
B : 저해제를 넣은 것의 반응 후 흡광도B: absorbance after the reaction of the inhibitor
C : 저해제를 넣지 않는 것의 반응 전 흡광도C: Absorbance before reaction of adding no inhibitor
D : 저해제를 넣지 않는 것의 반응 후 흡광도D: Absorbance after reaction of not adding inhibitor
티로시나제 활성 억제작용 시험결과 박 각 추출물의 IC50값은 0.2% 이하로 나타났다. 수치상으로 볼 때 다른 물질에 비해 저해활성이 약한 것으로 나타났으나, 코직산, 하이드로퀴논 등과 같이 순수정제된 물질이 아니라 추출물임을 감안한다면 우수한 효과를 가지는 것으로 판단된다.The test results of tyrosinase activity inhibition showed that the IC 50 value of the extract was less than 0.2%. Numerically, the inhibitory activity was found to be weaker than other substances, but it is considered to have an excellent effect considering that the extract is not a purely purified substance such as kojic acid or hydroquinone.
[표 3]TABLE 3
[실시예 5]Example 5
본 실시예는 방선균에 대한 멜라닌 생성 억제작용을 측정한 것으로 사용된 방선균(Strepthomyces bikiniensis NRRL B-1049)은 한국과학기술연구원 부설 유전공학연구소(KCTC)로부터 분양(기탁번호 KCTC 9172)받아 사용하였다.This example was used to measure melanin production inhibitory action against actinomycetes (Strepthomyces bikiniensis NRRL B-1049) was used (KCTC 9172) received from the Korea Institute of Science and Technology (KCTC).
방선균을 papavizas' VDYA 한천 슬랜트 배지(V-8 쥬스 200㎖, 포도당 2g, 효모추출물 2g, CaCO31g 한천 20g, 증류수 800㎖, pH7.2)에서 2주간 28℃로 배양시킨 포자를 생성시킨 후 멸균수로 포자 현탁액을 만들었다. 0.2%의 효모추출물은 첨가한 ISP No. 7 평판배지에 포자 현탁액 0.2㎖씩을 도포한 후 배지표면에 시료를 적신 페이퍼 디스크에 시료양을 30㎍/페이퍼 디스크로 도포하고 28℃에서 배양하였다. 48시간 배양 후 생성된 멜라닌 생성 저해환의 크기를 멜라닌생성 저해물질로 알려진 4-하이드록시아니솔을 대조군으로 하여 멜라닌생성 저해여부를 관찰하였다(표 4).Actinomycetes were spores cultured in papavizas' VDYA agar slant medium (V-8 juice 200ml, glucose 2g, yeast extract 2g, CaCO 3 1g agar 20g, distilled water 800ml, pH7.2) at 28 ° C for 2 weeks. The spore suspension was then made with sterile water. 0.2% yeast extract was added to ISP No. 7 0.2 ml each of the spore suspension was applied to the plate medium, and then the amount of the sample was applied to a paper disk moistened with the sample on the surface of the medium with 30 µg / paper disk and incubated at 28 ° C. The inhibition of melanogenesis was observed using the 4-hydroxyanisole known as the melanogenesis inhibitor as a control for the size of the melanogenesis inhibitors produced after 48 hours of incubation (Table 4).
박의 각 추출물의 방선균에 대한 멜라닌생성 저해활성은 박 에탄올추출물의 경우 20mm의 멜라닌 생성저해환을 나타내었다. 이러한 저해활성은 강력한 멜라닌 생성저해제인 4-하이드록시아니솔과 유사한 매우 우수한 활성을 나타내었다.Melanogenesis inhibitory activity against actinomycetes of each extract of gourd showed melanin production inhibition rate of 20 mm in the case of gourd ethanol extract. This inhibitory activity showed very good activity similar to 4-hydroxyanisole, a potent melanogenesis inhibitor.
[표 4]TABLE 4
[실시예 6]Example 6
본 실시예는 박의 물중탕 처리 물추출물, 에탄올추출물, 1,3-부틸렌글리콜과 물의 혼합액으로 추출한 추출물의 피부미백효과를 알아보기 위해 실험실수준에서 관찰한 것이다.This example was observed at the laboratory level to determine the skin whitening effect of the extract extracted with water bath treatment water extract, ethanol extract, 1,3-butylene glycol and a mixture of water.
본 실시예에 사용된 B16멜라노마 세포는 마우스에서 유래한 세포균주이며 멜라닌이라는 흑색색소를 분비하는 세포이다. 이 세포의 인공배양중에 시료를 처리하여 멜라닌 흑색색소가 감소하는 정도를 비교평가하였다. 본 실시예에 사용된 B16-F1 멜라노마 세포는 ATCC(American Type Culture Collection, 기탁번호 : 6323)로부터 분양받아 사용하였다.B16 melanoma cells used in this example are cell strains derived from mice and cells that secrete a black pigment called melanin. Samples were treated during the artificial culture of these cells to evaluate the degree of melanin black pigment reduction. The B16-F1 melanoma cells used in this example were used by being sold from the American Type Culture Collection (Accession No .: 6323).
B16-F1 멜라노마 세포의 멜라닌 생합성 저해도 판별은 다음과 같이 행하였다. B16-F1 멜라노마 세포를 5×103세포/㎖의 농도로 10% 소태아혈청을 포함하는 DMEM(Dulbecco's Modified Eagle's Medium(Gibco, USA))에 현탁시켰다. 현탁세포 5㎖를 조직배양 플라스크에 넣고 검정 시료를 0.1% 첨가한 후, 5% 이산화탄소-95%공기조건으로 37℃에서 배양하였다. 4일간 배양후 배양액의 색으로 멜라닌생성 정도를 1차 판별하고, 세포를 인산완충액으로 씻은 후 트립신처리하여 세포를 플라스크로부터 분리하였다. 세포를 튜브에 모은 후 인산완충액으로 씻고, 원심분리하여 튜브 아래쪽에 침전된 멜라닌 생성량을 기존의 미백제로 알려지고 있는 몇개의 시료와 박추출물과의 멜라닌색소분비억제 정도를 비교한 것이다. 평가방법은 세포배양중에 아무것도 처리하지 않은 것과 각 시료를 처리했을 때의 검은 멜라닌색소 분비정도에 따라 색상이 변화되는 정도를 육안관찰하여 상호비교 평가하였다. 결과적으로 박추출물이 멜라닌 색소분비를 효과적으로 억제한다는 결과를 얻었다(표 5).The inhibition of melanin biosynthesis of B16-F1 melanoma cells was determined as follows. B16-F1 melanoma cells were suspended in DMEM (Dulbecco's Modified Eagle's Medium (Gibco, USA)) containing 10% fetal bovine serum at a concentration of 5 × 10 3 cells / ml. 5 ml of suspension cells were added to a tissue culture flask, and 0.1% of the assay sample was added thereto, followed by incubation at 37 ° C under 5% carbon dioxide-95% air condition. After incubation for 4 days, the melanogenesis was first determined by the color of the culture medium, the cells were washed with phosphate buffer, and then trypsinized to separate the cells from the flask. The cells were collected in a tube, washed with phosphate buffer, and centrifuged to compare the amount of melanin produced by the whitening agent with the amount of melanin produced by the whitening agent. The evaluation method was evaluated by visual observation of the degree of color change according to the treatment of nothing in the cell culture and the degree of black melanin pigment secretion when each sample was treated. As a result, the extract was found to effectively inhibit melanin pigment secretion (Table 5).
[표 5]TABLE 5
[실시예 7, 8, 9][Example 7, 8, 9]
본 실시예에서는 실시예 1에 의해 추출한 각각의 박추출물을 함유한 화장료의 비교실험을 행하였다.In the present Example, the comparative experiment of the cosmetics containing each thin extract extracted by Example 1 was done.
비교실험에 사용된 크림의 조성은 표 6에 나타내었다. 우선 표 6에 기록되어 있는 나)상을 가열하여 70℃에 보존한다. 이것에 가)상을 가하여 예비유화 후 호모믹서로 균일하게 유화하고 다음에 서서히 냉각하여 크림(실시예 7~9, 비교예)을 조제하였다.The composition of the cream used in the comparative experiment is shown in Table 6. First, the phase b) recorded in Table 6 is heated and stored at 70 ° C. To this, a) phase was added, and after pre-emulsification, it was emulsified uniformly with a homomixer, and it cooled slowly, and the cream (Examples 7-9, a comparative example) was prepared.
표 6의 각 크림을 실험자(20~35세의 여성) 5명의 얼굴오른쪽에 1일 2회 연속 1개월간 도포하였다. 실험완료 후 얼굴 좌우 양편의 도포부위 피부를 화상분석기로 얼굴색을 비교하여 가장 어두운색을 5중간색을 3, 가장 환한 색을 1로 정하고 그 중간정도를 어림잡아 평가하였다. 표 7은 실시예 8의 조성으로 된 크림을 사용한 실험자의 안면피부색을 비교예의 조성으로 된 크림을 사용한 실험자의 안면사용부위와 비교한 것이다. 표 7에서와 같이 박추출물을 함유한 크림을 도포한 실험자의 안면에서 미백효과가 나타난 것을 알 수 있다.Each cream of Table 6 was applied to the right side of five subjects (20-35 year old female) for 2 consecutive days for 1 month. After completion of the experiment, the skins of the applied areas on both sides of the face were compared by using an image analyzer, and the darkest color was set as 5 medium color and the brightest color as 1, and the intermediate degree was estimated. Table 7 compares the facial skin color of the experimenter using the cream of the composition of Example 8 with the facial use area of the experimenter using the cream of the composition of the comparative example. As shown in Table 7, it can be seen that the whitening effect appeared on the face of the experimenter applying the cream containing the thin extract.
[표 6]TABLE 6
[표 7]TABLE 7
이하에 그 외의 실시예를 나타내었다. 즉, 상기한 바와 같이 피부개선에 우수한 효과를 나타내었으며 피부미용 효과를 나타내었다.Other examples are shown below. That is, as described above, it showed an excellent effect on skin improvement and a skin beauty effect.
[실시예 10]Example 10
95% 에탄올 8g에 폴리피롤리돈 0.05g, 올레일알콜 0.1g, 폴리옥시에틸렌모노올레이트 0.2g, 향료 0.2g, 파라옥시안식향산메틸에스테르 0.1g, 소량의 산화방지제, 소량의 색소를 혼합용해한다. 실시예 1의 박추출물 0.05g, 글리세린 5g를 정제수 85.33g에 용해한 것에 상기 혼합액을 교반첨가하여 피부개선 효과가 있는 화장수를 얻는다.To 8 g of 95% ethanol, 0.05 g of polypyrrolidone, 0.1 g of oleyl alcohol, 0.2 g of polyoxyethylene monooleate, 0.2 g of fragrance, 0.1 g of paraoxybenzoic acid methyl ester, a small amount of antioxidant, and a small amount of pigment are dissolved. 0.05 g of the extract extract of Example 1 and 5 g of glycerin were dissolved in 85.33 g of purified water, and the mixed solution was stirred and added to obtain a lotion having a skin improvement effect.
[실시예 11]Example 11
세틸알콜 1.2g, 스쿠알란 10g, 바세린 2g, 파라옥시안식향산에틸에스테르 0.2g, 글리세린모노에스테아레이드 1g, 폴리옥시에틸렌(20몰부가)모노올레이트 1g 및 향료 0.1g를 70℃에서 가열혼합 용해하고 실시예 1의 박추출물 0.5g, 디프로필렌글리콜 5g, 폴리에틸렌글리콜1500 2g, 트리에탄올아민 0.2g, 정제수 76.2g를 75℃로 가열해서 용해시킨다. 양자를 혼합하여 유화시킨 후 냉각하여 수/유중계형의 피부개선 효과가 있는 유액을 얻는다.1.2 g of cetyl alcohol, 10 g of squalane, 2 g of vaseline, 0.2 g of paraoxybenzoic acid ethyl ester, 1 g of glycerin monoesteralide, 1 g of polyoxyethylene (20 mole added) monooleate and 0.1 g of fragrance were mixed and dissolved at 70 ° C. 0.5 g of the thin extract of Example 1, 5 g of dipropylene glycol, 2 g of polyethylene glycol 1500, 0.2 g of triethanolamine, and 76.2 g of purified water were heated to 75 DEG C and dissolved. Both of them are emulsified by mixing and then cooled to obtain an emulsion having a water / oil-based skin improvement effect.
[실시예 12]Example 12
95% 에틸알콜 5g에 폴리옥시에틸렌 솔비탄모노올레이트 1.2g, 키툴로오즈 0.3g, 히야론산타트륨 0.2g, 비타민E 아세테이트 0.2g, 감초산나트륨 0.2g, 파라옥시안식향산에틸에스테르 0.1g, 실시예 1의 박추출물 1g 및 적량의 색소를 혼합하여 피부질개선의 효과가 있는 미용액을 얻는다.5 g of 95% ethyl alcohol, 1.2 g of polyoxyethylene sorbitan monooleate, 0.3 g of kitulose, 0.2 g of hyaluronic acid, 0.2 g of vitamin E acetate, 0.2 g of sodium licorice, 0.1 g of paraoxybenzoic acid ethyl ester, 1 g of the thin extract of Example 1 and a suitable amount of pigment are mixed to obtain a cosmetic liquid having an effect of improving the skin.
본 발명에 의한 박추출물은 각종 피부손상의 방지 및 개선효과가 탁월하며 안전성면에서도 매우 우수하다. 또한, 상술한 박추출물은 피부화장료에 적용이 가능하고 화장료에 함유시 우수한 미백효과 및 항산화효과를 나타낸다.The extract according to the present invention is excellent in preventing and improving various skin damages and is very excellent in terms of safety. In addition, the above-mentioned thin extract is applicable to skin cosmetics and exhibits excellent whitening and antioxidant effects when contained in cosmetics.
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019970006624A KR19980069516A (en) | 1997-02-28 | 1997-02-28 | Extract and skin cosmetic containing same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019970006624A KR19980069516A (en) | 1997-02-28 | 1997-02-28 | Extract and skin cosmetic containing same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR19980069516A true KR19980069516A (en) | 1998-10-26 |
Family
ID=65985496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019970006624A Ceased KR19980069516A (en) | 1997-02-28 | 1997-02-28 | Extract and skin cosmetic containing same |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR19980069516A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111228162A (en) * | 2018-11-28 | 2020-06-05 | 阿尔卑斯村庄营农组合法人 | Cosmetic composition containing Cucurbita pepo extract for whitening, resisting oxidation and keeping moisture, and its preparation method |
-
1997
- 1997-02-28 KR KR1019970006624A patent/KR19980069516A/en not_active Ceased
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111228162A (en) * | 2018-11-28 | 2020-06-05 | 阿尔卑斯村庄营农组合法人 | Cosmetic composition containing Cucurbita pepo extract for whitening, resisting oxidation and keeping moisture, and its preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3415198B2 (en) | External preparation for skin | |
| KR101387308B1 (en) | Skin whitening composition by using of dendropanax morbifera ferment extract | |
| KR101336804B1 (en) | Fermented ear shell using mushroom, manufacturing method thereof and cosmetic composition comprising the same | |
| KR20170052811A (en) | yeast fermented solutions of green tea extract and manufacturing method thereof and cosmetic composition using the same | |
| JP5142113B2 (en) | Melanin production inhibitor and use thereof | |
| KR101825704B1 (en) | A cosmetic composition comprising coffee silver skin extract | |
| KR101769755B1 (en) | A leuconostoc mesenteroides gfc 160704, cosmetic composition including the leuconostoc mesenteroides gfc 160704 or its culture fluid, and manufacturing method of the cosmetic composition | |
| JP2011042644A (en) | Composition for beautification | |
| KR20210144725A (en) | Anti-aging, antioxidant, anti-inflammatory and whitening agents, and cosmetics | |
| KR101685579B1 (en) | Method for manufacturing skin-whitener composition containing Thuja orientalis and skin-whitener composition prepared therefrom | |
| KR20110122448A (en) | Cosmetic composition containing gelatin paste extract as an active ingredient | |
| KR20170076147A (en) | Composition for improving skin | |
| KR100206538B1 (en) | Cosmetic composition for skin whitening containing situation mushroom powder extract | |
| KR101810410B1 (en) | Method for Preparing Extracts of Mixed Culture of Green Rye Placenta and Mushroom Mycelium and Cosmetic Composition Containing the Same | |
| EP2291173B1 (en) | Combination of passion flower and alkanet extracts for use in cosmetics | |
| KR101957435B1 (en) | Method for preparing extract of fermented silkworm cocoon for improving antiwrinkle and a cosmetic composition containing the fermented extract of silkworm cocoon as an active ingredients | |
| KR100883773B1 (en) | Cosmetic composition comprising as an active ingredient salted fermented extract of citron or citrus fruit | |
| KR19990081226A (en) | Skin cosmetic using natural mushrooms | |
| JP2000319122A (en) | Cell proliferation promoting cosmetic | |
| KR20020033034A (en) | Skin cosmetics using long headed ginseng and mountain ginseng | |
| KR19980069516A (en) | Extract and skin cosmetic containing same | |
| KR102168533B1 (en) | Cosmetic composition for whitening or improving the facial color containing herb extracts | |
| KR100334608B1 (en) | Cosmetic compositions comprising pleurotus ostreatus extract | |
| KR20000007943A (en) | Whitening cosmetic containing extracts from a bamboo endothelium | |
| KR100508528B1 (en) | method for manufacturng the Skin Cosmetics using horse bean and Golden larch extract |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19970228 |
|
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 19970228 Comment text: Request for Examination of Application |
|
| PG1501 | Laying open of application | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 19981221 Patent event code: PE09021S01D |
|
| AMND | Amendment | ||
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 19990330 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 19981221 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
| J201 | Request for trial against refusal decision | ||
| PJ0201 | Trial against decision of rejection |
Patent event date: 19990506 Comment text: Request for Trial against Decision on Refusal Patent event code: PJ02012R01D Patent event date: 19990330 Comment text: Decision to Refuse Application Patent event code: PJ02011S01I Appeal kind category: Appeal against decision to decline refusal Decision date: 20000630 Appeal identifier: 1999101001643 Request date: 19990506 |
|
| PB0901 | Examination by re-examination before a trial |
Comment text: Request for Trial against Decision on Refusal Patent event date: 19990506 Patent event code: PB09011R01I Comment text: Amendment to Specification, etc. Patent event date: 19990220 Patent event code: PB09011R02I |
|
| B601 | Maintenance of original decision after re-examination before a trial | ||
| PB0601 | Maintenance of original decision after re-examination before a trial | ||
| J301 | Trial decision |
Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 19990506 Effective date: 20000630 |
|
| PJ1301 | Trial decision |
Patent event code: PJ13011S01D Patent event date: 20000713 Comment text: Trial Decision on Objection to Decision on Refusal Appeal kind category: Appeal against decision to decline refusal Request date: 19990506 Decision date: 20000630 Appeal identifier: 1999101001643 |